“…In rats and mice, bilateral lesions of the superior colliculus, microinjection of GABA antagonist (Depaulis et al, 1990 ), N -methyl-D-aspartate (NMDA) antagonist (Faingold and Casebeer, 1999a ; Raisinghani and Faingold, 2003 ) or alpha1-noradrenergic agonist (Faingold and Casebeer, 1999a ) markedly attenuated AGS severity (Merrill et al, 2003 ). In a different approach, optogenetic activation of DLSC also attenuates seizures in Genetically Epilepsy-Prone Rat (GEPR) 3 substrain (Soper et al, 2016 ; Wicker et al, 2019 ). Activation of the DLSC also potently suppresses seizures in other models of epilepsy, including the maximal electroshock model (Redgrave et al, 1992 ; Gale et al, 1993 ), evoked and genetic absence seizure models (Nail-Boucherie et al, 2002 , 2005 ; Soper et al, 2016 ); the Area Tempestas (AT) model of forebrain seizures (Soper et al, 2016 ), and the pentylenetetrazole model of generalized seizures (Weng and Rosenberg, 1992 ; Soper et al, 2016 ).…”